ResMed Inc/ US7611521078 /
| 2024-07-24 9:59:59 PM | Chg. -3.20 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 206.32USD | -1.53% | 27,334 Turnover: 5.68 mill. |
-Bid Size: - | -Ask Size: - | 30.29 bill.USD | 0.85% | 33.69 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 6.12 USD | 14.61% |
| EPS Diluted: | 6.09 USD | 14.91% |
| Revenues per Share: | 28.71 USD | 17.50% |
| Book Value per Share: | 28.08 USD | 22.35% |
| Cash Flow per Share: | 4.71 USD | 96.57% |
| Dividend per Share: | 1.76 USD | 4.76% |
| Total | in mill. | |
| Revenues: | 4,222.99 USD | 18.02% |
| Net Income: | 897.56 USD | 15.15% |
| Operating Cash Flow: | 693.30 USD | - |
| Cash and Cash Equivalents: | 227.89 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 33.69 | 35.70 |
| P/S Ratio: | 7.18 | 7.61 |
| P/BV ratio: | 7.34 | 7.78 |
| P/CF Ratio: | 43.74 | 46.35 |
| PEG: | 2.31 | 2.44 |
| Earnings Yield: | 2.97% | 2.80% |
| Dividend Yield: | 0.85% | 0.81% |
| Market Capitalization | ||
| Market Capitalization: | 30.29 bill. USD | 32.14 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 146.91 mill. | |
Profitability
| Gross Profit Margin: | 55.78% |
| EBIT Margin: | 26.80% |
| Net Profit Margin: | 21.25% |
| Return on Equity: | 21.73% |
| Return on Assets: | 13.29% |
Financial Strength
| Liquidity I / Cash Ratio: | 30.04% |
| Liquidity II / Quick Ratio: | 122.97% |
| Liquidity III / Current Ratio: | 312.16% |
| Debt / Equity Ratio: | 63.48% |
| Dynam. Debt / Equity Ratio: | 378.16% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-06-30 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
